Aspiriant Risk Managed Equity Fund Manager Performance Evaluation
| RMEAX Fund | USD 16.49 0.14 0.86% |
The fund shows a Beta (market volatility) of 0.62, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aspiriant Risk-managed's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aspiriant Risk-managed is expected to be smaller as well.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Aspiriant Risk Managed Equity are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Aspiriant Risk-managed showed solid returns over the last few months and may actually be approaching a breakup point.
...moreAspiriant |
Aspiriant Risk-managed Relative Risk vs. Return Landscape
If you would invest 1,420 in Aspiriant Risk Managed Equity on October 24, 2025 and sell it today you would earn a total of 229.00 from holding Aspiriant Risk Managed Equity or generate 16.13% return on investment over 90 days. Aspiriant Risk Managed Equity is currently producing 0.257% returns and takes up 1.5852% volatility of returns over 90 trading days. Put another way, 14% of traded mutual funds are less volatile than Aspiriant, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Aspiriant Risk-managed Current Valuation
Fairly Valued
Today
Please note that Aspiriant Risk-managed's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Aspiriant Risk Managed shows a prevailing Real Value of $16.2 per share. The current price of the fund is $16.49. We determine the value of Aspiriant Risk Managed from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Aspiriant Risk-managed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aspiriant Mutual Fund. However, Aspiriant Risk-managed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.49 | Real 16.2 | Hype 16.49 | Naive 15.78 |
The intrinsic value of Aspiriant Risk-managed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aspiriant Risk-managed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aspiriant Risk Managed Equity helps investors to forecast how Aspiriant mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aspiriant Risk-managed more accurately as focusing exclusively on Aspiriant Risk-managed's fundamentals will not take into account other important factors: Aspiriant Risk-managed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aspiriant Risk-managed's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Aspiriant Risk Managed Equity, and traders can use it to determine the average amount a Aspiriant Risk-managed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average Aspiriant Risk-managed is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aspiriant Risk-managed by adding it to a well-diversified portfolio.
Aspiriant Risk-managed Fundamentals Growth
Aspiriant Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Aspiriant Risk-managed, and Aspiriant Risk-managed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aspiriant Mutual Fund performance.
| Price To Earning | 17.42 X | |||
| Price To Book | 2.25 X | |||
| Price To Sales | 1.63 X | |||
| Total Asset | 1.82 B | |||
About Aspiriant Risk-managed Performance
Evaluating Aspiriant Risk-managed's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Aspiriant Risk-managed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aspiriant Risk-managed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund will invest at least 80 percent of its net assets in equity securities. Aspiriant Risk-Managed is traded on NASDAQ Exchange in the United States.Things to note about Aspiriant Risk Managed performance evaluation
Checking the ongoing alerts about Aspiriant Risk-managed for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Aspiriant Risk Managed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The fund maintains about 7.62% of its assets in cash |
- Analyzing Aspiriant Risk-managed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aspiriant Risk-managed's stock is overvalued or undervalued compared to its peers.
- Examining Aspiriant Risk-managed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aspiriant Risk-managed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aspiriant Risk-managed's management team can help you assess the Mutual Fund's leadership.
- Pay attention to analyst opinions and ratings of Aspiriant Risk-managed's mutual fund. These opinions can provide insight into Aspiriant Risk-managed's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Aspiriant Mutual Fund
Aspiriant Risk-managed financial ratios help investors to determine whether Aspiriant Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aspiriant with respect to the benefits of owning Aspiriant Risk-managed security.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |